Video-assisted Thyroid Surgery and Hypnosis in Thyroid Surgery

Combination of Video-assisted Thyroid Surgery and Hypnosis as a Complete Minimally Invasive Approach: a Comparative Pilot Study

The study is aimed to investigate the safety and feasibility of Video-assisted thyroidectomy under hypnosis in comparison to general anesthesia

Study Overview

Detailed Description

Summary of the project

video-assisted thyroidectomy (MIVAT): General anesthesia (GA) versus hypnosis (HY)

Investigators

Prof. Michel Mourad*, Dr. Christine Watremez **, Prof. Fabienne Roelants**

* Surgery and Abdominal Transplantation Division

** Department of Anesthesiology,

Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium

  1. Aim

    The aim of this pilot study is to prospectively investigate, in a consecutive series of patients, the feasibility and safety of MIVAT under HY associated with local anesthesia, compared to GA.

  2. Inclusion criteria

    • Adult patients candidates to total or partial thyroidectomy.
    • ASA 1, 2 or 3
    • One surgeon (MM)
    • Informed consent
  3. Exclusion criteria

    • Age <18 years
    • The presence of familial medullary thyroid cancers
    • Suspicious or metastatic lymph nodes
    • Redo surgery
    • ASA 4 patients
    • Patients with chronic pain
    • Deaf people
    • Patients with psychiatric diseases
    • Known recurrent nerve paralysis
  4. Outcome evaluation

    • Primary outcomes: safety and feasibility.
    • During surgery, considered events for analysis should include operating time (from skin incision to skin closure), total time in the operating room, intraoperative bleeding, drug consumption, Hemodynamic changes and conversion rates from MIVAT to a conventional approach and from HY to GA.
    • After surgery, comparative variables for analysis should include: drug consumption, hospital stay, calcemia, and vocal cord abnormality on the basis of day-one laryngoscopy performed by an ENT doctor not involved in the study.
  5. Patients selection and study groups:

Selection of patients for MIVAT is based on the size of the gland and nodules, provided that the craniocaudal axis of the lobes did not exceed 7cm and the largest transversal diameter was less than 3.5cm. All patients who are assigned to undergo MIVAT are instructed about the possibility of conversion to a conventional approach. The patients are left free to choose the type of anesthesia they prefere for their surgical intervention. They have to give informed consent before the procedure.

A. General anesthesia group:

Premedication:

  • Lorazepam 0.5 mg 1 h before surgery
  • ECG, NIBP, SaO2
  • VVP + NaCl 0.9 % 500 mL + taradyl 0.5 mg / kg (<30 mg)

Induction:

  • Remifentanil 0.05 µg/kg/min
  • Propofol 2 mg/kg
  • Intubation with an armored endotracheal tube specially devised for neuromonitoring of the vocal cords.

During surgery:

  • Sevoflurane / Remifentanil

B. Hypnosis group:

Premedication:

  • Lorazepam 0.5 mg 1 h avant l'intervention
  • ECG, NIBP, SaO2
  • VVP + NaCl 0.9 % 500 mL + taradyl 0.5 mg / kg (< 30 mg)

Induction and during surgery:

  • Remifentanil modified as requested
  • Induction of hypnosis according to Milton Eriksson technique
  • Midazolam (titrated 0.1 mg/0.1mg) if needed as anxiolytic.
  • Local anesthesia mixture (lidocaine 0.5%/ropivacaine 0.25%) to be administered by the surgeon along the incision line 5 minutes before making the skin incision.

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1200
        • Cliniques Universitaires Saint-Luc. 10 Avenue Hippocrate

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The selection of patients for MIVAT was achieved according to the size of the gland and nodules provided that the cranio-caudal axis of the lobes does not exceed 7 centimeters and the largest transversal diameter is less than 3.5 centimeters
  • Age >18 years

Exclusion Criteria:

  • No previous neck surgery
  • No known malignancy
  • No history of neck irradiation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypnosis and local anesthesia
video-assisted thyroidectomy under hypnosis and local anesthesia.
Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis
Active Comparator: General anesthesia
Video-assisted thyroidectomy under general anesthesia
Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility
Time Frame: Intraoperative
To assess technical feasibility
Intraoperative

Secondary Outcome Measures

Outcome Measure
Time Frame
Operating time
Time Frame: during surgery
during surgery
Intraoperative bleeding
Time Frame: During surgery
During surgery
Conversion to general anesthesia
Time Frame: During surgery
During surgery
Conversion from video-assisted technique to conventional surgery
Time Frame: During surgery
During surgery

Other Outcome Measures

Outcome Measure
Time Frame
Hemodynamic changes
Time Frame: During surgery
During surgery
Drug consumption
Time Frame: During surgery and up to 6 hours after surgery
During surgery and up to 6 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michel Mourad, MD, PhD, Cliniques Universitaires Saint-Luc. 10 Avenue Hippocrate, 10. 1200 Bruxelles

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

October 31, 2012

First Submitted That Met QC Criteria

December 18, 2012

First Posted (Estimate)

December 19, 2012

Study Record Updates

Last Update Posted (Estimate)

December 19, 2012

Last Update Submitted That Met QC Criteria

December 18, 2012

Last Verified

December 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Video-Hypnose

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on video-assisted thyroidectomy

Subscribe